An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these profiles privately for source information, while also obtaining discount codes.
Active Trade on Social Networks
Separately, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for transactions.
Understanding Retatrutide
This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Experts Voice Concerns
However, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in individuals administering substances of unknown origin.
Several professionals said the demand for the experimental drug could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to penalties, legal action or prison.
Service Reaction and Material Removal
Based on the social media company, the service has removed violative content and banned related keywords and query recommendations. The organization said it was dedicated to keeping the platform secure and investing in strengthening compliance measures.
Digital Trading Operations
Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of users, populated with photos of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at residence.
Within minutes of joining one community, a vendor shared WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.
Product Details and Costs
Within these communities, posts show dark colored packages with postal service labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for the messaging service stated it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting materials they can’t verify. Even if the science behind retatrutide is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.
Her team has already seen individuals injured by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”
Producer Position
A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly investigational product not yet authorized … may subject users to potentially significant medical dangers”.
